ResMed | RMD - Operating Profit

Stock Price
221.06
Daily Change
1.21 0.55%
Monthly
-2.32%
Yearly
-6.28%
Q2 Forecast
215.15

ResMed reported $497.6M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Ansell USD 146.5M 87.85M Dec/2025
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 2.49M 2.28M Dec/2025
Baxter International USD -214.2M 415.4M Dec/2025
Cochlear AUD 261.1M 135.55M Dec/2025
Cooper Companies USD 212.8M 72.4M Dec/2025
CSL USD 2.64B 1.97B Dec/2025
Dexcom USD 323M 80.5M Dec/2025
Edwards Lifesciences USD 514.7M 144.4M Mar/2026
Fisher Paykel Healthcare NZD 298.2M 2.8M Dec/2025
Globus Medical USD 181.31M 298.83M Dec/2025
Haemonetics USD 67.4M 8.9M Dec/2025
Idexx Laboratories USD 315.6M 39.24M Dec/2025
Inogen USD -7.79M 728K Sep/2024
Insulet USD 146.3M 28.6M Dec/2025
Integra LifeSciences USD 66M 54.24M Dec/2025
Intuitive Surgical USD 859.7M 5.6M Mar/2026
Masimo USD 83.9M 300K Dec/2025
Medtronic USD 1.74B 40M Dec/2025
Philips EUR 719M 390M Dec/2025
Ramsay Health Care AUD 541.1M 3.9M Dec/2025
ResMed USD 497.6M 35.25M Dec/2025
Sigma Healthcare AUD 809K 13.76M Dec/2024
Sonic Healthcare AUD 435.76M 193.66M Dec/2024
Steris USD 278M 7.1M Dec/2025
Teleflex USD 36.34M 445.24M Dec/2025
Thermo Fisher Scientific USD 1.91B 389M Mar/2026